In light of the unexpected correction that occurred Sunday through Tuesday this week, and the strong rebound since, I thought it important to take another macro look at this in the context of the Wyckoff Method for interpreting the price action.
What we can see since the low of June 22 are clear correspondences to re-occurring distribution and accumulation phases in an escalating Markup/Markdown price cycle.
With the latest low looking like a picture perfect ‘spring’ for new highs, I suspect we are now moving into and extended Markup cycle, as we start tracking the milestones through the Distribution phases.
With price already rebounding over $44.8k, a Sign of Strength (SOS) above $48.8, on the other side of the new Wyckoff Creek, is a sure sign that we should be seeking to identify the next Buying Climax (BC). How high that will be is a guess, but given the maturity of this halving cycle, I suspect between $84k and $94k.
What do you think? Is the Composite Man reaccumulating to maximise profit potential from this cycle, or is it all just an irrelevant movement in what is now a bear market?
What we can see since the low of June 22 are clear correspondences to re-occurring distribution and accumulation phases in an escalating Markup/Markdown price cycle.
With the latest low looking like a picture perfect ‘spring’ for new highs, I suspect we are now moving into and extended Markup cycle, as we start tracking the milestones through the Distribution phases.
With price already rebounding over $44.8k, a Sign of Strength (SOS) above $48.8, on the other side of the new Wyckoff Creek, is a sure sign that we should be seeking to identify the next Buying Climax (BC). How high that will be is a guess, but given the maturity of this halving cycle, I suspect between $84k and $94k.
What do you think? Is the Composite Man reaccumulating to maximise profit potential from this cycle, or is it all just an irrelevant movement in what is now a bear market?
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。